Capstone Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$955K Buy
11,200
+3,700
+49% +$330K ﹤0.01% 876
2025
Q4
$593K Sell
7,500
-5,700
-43% -$447K ﹤0.01% 1086
2025
Q3
$1.06M Buy
13,200
+8,000
+154% +$682K ﹤0.01% 996
2025
Q2
$473K Sell
5,200
-18,500
-78% -$1.69M ﹤0.01% 1169
2025
Q1
$2.22M Sell
23,700
-30,000
-56% -$2.69M 0.01% 655
2024
Q4
$4.88M Buy
53,700
+11,000
+26% +$1.05M 0.01% 549
2024
Q3
$4.43M Buy
42,700
+1,400
+3% +$143K 0.01% 493
2024
Q2
$4.01M Buy
41,300
+4,100
+11% +$378K 0.01% 507
2024
Q1
$3.35M Sell
37,200
-16,200
-30% -$1.37M 0.01% 583
2023
Q4
$4.26M Buy
53,400
+32,300
+153% +$2.43M 0.01% 590
2023
Q3
$1.5M Sell
21,100
-1,700
-7% -$127K 0.01% 832
2023
Q2
$1.76M Buy
22,800
+1,100
+5% +$85.1K 0.01% 684
2023
Q1
$1.63M Buy
21,700
+6,100
+39% +$454K 0.01% 647
2022
Q4
$1.23M Buy
15,600
+2,500
+19% +$187K 0.01% 864
2022
Q3
$920K Sell
13,100
-900
-6% -$70.6K 0.01% 1064
2022
Q2
$1.12M Sell
14,000
-59,400
-81% -$4.64M 0.01% 964
2022
Q1
$5.57M Sell
73,400
-65,900
-47% -$5.22M 0.02% 664
2021
Q4
$11.9M Sell
139,300
-20,500
-13% -$1.6M 0.02% 554
2021
Q3
$12.1M Buy
159,800
+36,000
+29% +$2.86M 0.02% 558
2021
Q2
$10.1M Buy
123,800
+3,800
+3% +$311K 0.02% 533
2021
Q1
$9.46M Buy
120,000
+4,100
+4% +$321K 0.03% 476
2020
Q4
$9.91M Buy
115,900
+31,300
+37% +$2.59M 0.03% 406
2020
Q3
$6.53M Buy
84,600
+27,800
+49% +$2.12M 0.03% 442
2020
Q2
$4.16M Buy
56,800
+16,000
+39% +$1.14M 0.03% 489
2020
Q1
$2.71M Sell
40,800
-46,100
-53% -$3.25M 0.04% 431
2019
Q4
$5.98M Buy
86,900
+400
+0.5% +$27.3K 0.03% 499
2019
Q3
$6.36M Buy
86,500
+32,100
+59% +$2.33M 0.04% 383
2019
Q2
$3.9M Buy
54,400
+16,500
+44% +$1.17M 0.03% 530
2019
Q1
$2.6M Buy
37,900
+11,800
+45% +$762K 0.02% 512
2018
Q4
$1.55M Buy
26,100
+11,100
+74% +$694K 0.02% 502
2018
Q3
$1M Buy
+15,000
New +$999K 0.01% 592
2017
Q1
Sell
-4,000
Closed -$261K 906
2016
Q4
$261K Buy
+4,000
New +$274K 0.01% 764
2016
Q1
Sell
-309,200
Closed -$20.6M 658
2015
Q4
$20.6M Buy
309,200
+239,200
+342% +$15.9M 0.55% 41
2015
Q3
$4.44M Buy
70,000
+6,200
+10% +$405K 0.1% 145
2015
Q2
$4.17M Sell
63,800
-21,100
-25% -$1.43M 0.06% 183
2015
Q1
$5.89M Buy
84,900
+27,200
+47% +$1.88M 0.1% 137
2014
Q4
$3.99M Sell
57,700
-62,000
-52% -$4.19M 0.06% 182
2014
Q3
$7.81M Buy
+119,700
New +$7.89M 0.09% 180
2014
Q2
Sell
-70,000
Closed -$4.54M 410
2014
Q1
$4.54M Hold
70,000
0.06% 172
2013
Q4
$4.56M Hold
70,000
0.05% 214
2013
Q3
$4.15M Buy
+70,000
New +$4.15M 0.04% 227

Other funds holding CL

Capstone Investment Advisors's CL Position: Q1 2026 in Review

Capstone Investment Advisors increased its Colgate-Palmolive (CL) stake by 318% in Q1 2026, buying an estimated $11.2M and bringing the position to 165,075 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #236.

Capstone Investment Advisors first reported a position in CL in Q2 2014 and has held it in 32 quarters since. The position peaked at $16.6M in Q4 2014. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capstone Investment Advisors held 165,075 shares of Colgate-Palmolive worth $14.1M as of Q1 2026.
  • Capstone Investment Advisors bought 125,624 Colgate-Palmolive shares in Q1 2026, an estimated $11.2M.
  • Colgate-Palmolive made up 0.02% of Capstone Investment Advisors's portfolio in Q1 2026, its #236 holding.
  • Capstone Investment Advisors first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 32 quarters since.
  • Capstone Investment Advisors's Colgate-Palmolive position peaked at $16.6M in Q4 2014.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.